https://heartzone.it/parliamo-di-minoca-ci-sono-novita/2026-05-27T18:10:38+02:00https://heartzone.it/digitale-un-passo-avanti-e-uno-indietro-gli-studi-recenti-con-digitale-per-lo-scompenso-cardiaco/2026-05-27T18:08:39+02:00https://heartzone.it/hai-lo-scompenso-si-capisce-dalla-voce/2026-05-27T18:06:55+02:00https://heartzone.it/silenzio-entra-la-corte-i-dolori-della-signorina/2026-05-15T10:23:47+02:00https://heartzone.it/embolia-polmonare-e-cambiato-qualcosa/2026-05-14T16:31:34+02:00https://heartzone.it/parole-che-curano-un-percorso-sulla-relazione-medico-paziente-in-ortopedia/2026-05-15T09:58:23+02:00https://heartzone.it/poco-alcol-fa-bene-al-cuore-ma-solo-se-e-vino/2026-04-23T00:06:13+02:00https://heartzone.it/tirzepatide-vs-semaglutide-un-confronto-ragionato-al-di-la-dei-surpass/2026-04-23T00:04:12+02:00https://heartzone.it/clopidogrel-o-asa-per-la-monoterapia-dopo-pci-follow-up-a-10-anni-dello-studio-host-exam/2026-04-23T00:07:37+02:00https://heartzone.it/i-betabloccanti-nel-post-infarto-farne-a-meno-si-puo-lo-studio-smart-decison/2026-04-16T11:51:54+02:00https://heartzone.it/quando-il-diavolo-ci-mette-la-coda-spironolattone-nello-scompenso-cardiaco-a-frazione-di-eiezione-preservata-lo-studio-spirit-hf/2026-04-16T11:50:31+02:00https://heartzone.it/ci-sono-le-prove-la-riduzione-di-ldl-c-deve-essere-intensa-e-precoce-i-risultati-dello-studio-ez-pave/2026-04-09T11:54:52+02:00https://heartzone.it/tempo-di-cambiare-la-lezione-del-vesalius-cv-sui-pazienti-senza-aterosclerosi/2026-04-09T11:36:46+02:00https://heartzone.it/chiusura-dellauricola-o-anticoagulanti-il-confronto-continua-lo-studio-champion-af/2026-04-02T12:01:01+02:00https://heartzone.it/trombolisi-catetere-diretta-batte-anticoagulazione-nellembolia-polmonare-a-rischio-intermedio-lo-studio-hi-peitho/2026-04-02T11:59:44+02:00https://heartzone.it/francesco-tassone/2026-04-07T11:35:51+02:00https://heartzone.it/gioia-filomena/2026-04-07T11:35:34+02:00https://heartzone.it/fabrizia-toscanella/2026-04-07T11:35:12+02:00https://heartzone.it/gerardo-corigliano/2026-04-07T11:34:49+02:00https://heartzone.it/francesco-caraffa/2026-04-07T11:34:23+02:00https://heartzone.it/domenico-bernardino-maiolo/2026-04-07T11:33:57+02:00https://heartzone.it/rischio-emorragico-e-ischemico-nelle-acs-come-scegliere-il-male-minore/2026-03-26T10:25:32+01:00https://heartzone.it/tra-rivaroxaban-e-apixaban-ce-un-vincitore-lo-studio-cobrra-nel-trattamento-del-tev/2026-03-25T16:28:23+01:00https://heartzone.it/parole-che-curano-un-percorso-sulla-relazione-medico-paziente/2026-03-25T17:18:17+01:00https://heartzone.it/quando-serve-fermarsi-stop-alle-terapie-cardiologiche-croniche-nel-fine-vita/2026-03-16T18:43:45+01:00https://heartzone.it/sorpassiamo-il-rischio-cardiovascolare-tirzepatide-e-dulaglutide-a-confronto-i-risultati-dello-studio-surpass-cvot/2026-03-16T18:43:37+01:00https://heartzone.it/i-nutraceutici-nelle-dislipidemie-hanno-ancora-un-senso/2026-03-04T11:29:30+01:00https://heartzone.it/i-trattamenti-per-il-paziente-con-sindrome-coronarica-cronica-limbarazzo-della-scelta/2026-02-26T15:43:00+01:00https://heartzone.it/se-cera-bisogno-di-un-anti-pcsk9-orale-ecco-enlicitide-i-risultati-dello-studio-coral-reef-lipids/2026-02-12T16:00:36+01:00https://heartzone.it/partenza-in-salita-per-lintelligenza-artificiale-nelle-diagnosi-cardiologiche-i-risultati-dello-studio-tricorder/2026-02-12T16:00:34+01:00https://heartzone.it/gli-anticoagulanti-anti-fattore-xi-fanno-dei-giri-immensi-e-poi-ritornano/2026-02-02T13:53:58+01:00https://heartzone.it/fibrillazione-atriale-lora-dello-screening-le-opportunita-di-uno-smartwatch/2026-02-02T14:35:08+01:00https://heartzone.it/omega-3-e-rischio-di-fa-cerchiamo-di-capire/2026-01-22T17:19:44+01:00https://heartzone.it/il-caffe-favorisce-le-aritmie-solo-un-luogo-comune/2026-01-22T17:18:37+01:00https://heartzone.it/stefano-ciardullo/2026-03-16T18:56:38+01:00https://heartzone.it/marco-grasso/2026-03-16T18:56:41+01:00https://heartzone.it/rosanna-donvito/2026-03-23T11:27:51+01:00https://heartzone.it/maura-gardinali-2/2026-03-23T11:27:43+01:00https://heartzone.it/loredana-bucciarelli/2026-03-16T19:35:16+01:00https://heartzone.it/antonio-labate/2026-03-16T19:34:51+01:00https://heartzone.it/baldassarre-grassa/2026-03-16T19:34:16+01:00https://heartzone.it/maria-pia-riccio/2026-03-16T19:33:36+01:00https://heartzone.it/davide-menafra/2026-03-16T19:32:16+01:00https://heartzone.it/stefania-anna-fontanarosa/2026-03-16T19:31:28+01:00https://heartzone.it/angela-carlone/2026-03-16T19:30:37+01:00https://heartzone.it/maura-gardinali/2026-03-16T19:30:06+01:00https://heartzone.it/diego-mastino/2026-03-16T19:29:06+01:00https://heartzone.it/fabiana-picconi/2026-03-16T19:21:57+01:00https://heartzone.it/francesca-pancani/2026-03-16T19:20:37+01:00https://heartzone.it/cristina-parrino/2026-03-16T19:21:14+01:00https://heartzone.it/gianluca-lombardi/2026-03-16T19:11:46+01:00https://heartzone.it/martina-chiriaco/2026-03-16T19:11:52+01:00https://heartzone.it/massimiliano-caprio-2/2026-03-16T19:11:30+01:00https://heartzone.it/marco-giorgio-baroni/2026-03-16T19:11:39+01:00https://heartzone.it/lo-smart-risk-score-i-pazienti-in-prevenzione-secondaria-non-sono-tutti-uguali/2026-01-15T16:47:04+01:00https://heartzone.it/fda-ferma-lantidoto-per-i-doac-anti-fattore-xa-meglio-tardi-che/2026-01-15T16:46:11+01:00https://heartzone.it/impatto-di-evolocumab-nel-ridurre-gli-eventi-cardiovascolari-nel-mondo-reale-novita-dai-congresso-aha-2025/2026-01-15T16:48:46+01:00https://heartzone.it/colchicina-e-ora-approvata-per-la-prevenzione-secondaria-nei-pazienti-con-malattia-coronarica-cronica-a-quale-paziente/2025-12-04T16:24:41+01:00https://heartzone.it/concetti-di-farmacoeconomia-nella-profilassi-del-tev/2025-12-04T16:22:17+01:00https://heartzone.it/come-trattare-una-complicazione-trombotica-in-un-paziente-oncologico-caso-clinico/2025-12-04T16:20:53+01:00https://heartzone.it/carlo-casile/2025-12-04T16:19:08+01:00https://heartzone.it/colchicina-e-ora-approvata-per-la-prevenzione-secondaria-nei-pazienti-con-malattia-coronarica-cronica-levidenza-dei-trial-clinici/2025-11-27T13:09:56+01:00https://heartzone.it/colchicina-e-ora-approvata-per-la-prevenzione-secondaria-nei-pazienti-con-malattia-coronarica-cronica-il-suo-impiego-pratico/2025-11-27T13:08:26+01:00https://heartzone.it/profilassi-del-tev-in-alcune-categorie-di-pazienti-stroke-e-cirrosi/2025-11-27T13:06:45+01:00https://heartzone.it/sara-volpe/2025-11-27T13:02:43+01:00https://heartzone.it/paola-orsini/2025-11-27T13:02:26+01:00https://heartzone.it/prevenzione-primaria-del-rischio-molto-alto-la-risposta-del-vesalio/2025-11-13T09:35:31+01:00https://heartzone.it/profilassi-tev-nei-bambini-e-adolescenti/2025-11-20T12:06:08+01:00https://heartzone.it/profilassi-tev-nei-pazienti-sottopeso/2025-11-20T12:05:57+01:00https://heartzone.it/emergenza-urgenza-valutazione-del-rischio-tev/2025-11-13T09:16:44+01:00https://heartzone.it/ma-e-vero-che-il-caffe-fa-alzare-i-livelli-di-colesterolo/2025-10-30T12:49:07+01:00https://heartzone.it/paola-romagni/2025-10-30T12:48:47+01:00https://heartzone.it/antonello-selleri/2025-10-30T12:52:43+01:00https://heartzone.it/i-pazienti-a-rischio-cv-molto-elevato-del-territorio-di-mezzo-quelli-che-non-hanno-avuto-un-pregresso-evento/2025-10-30T12:50:30+01:00https://heartzone.it/profilassi-del-tev-e-terapie-concomitanti-gli-antipiastrinici/2025-10-30T12:45:03+01:00https://heartzone.it/recidiva-di-stroke-nel-paziente-fibrillante-anticoagulato-chiudere-lauricola-e-poi/2025-10-23T09:38:37+02:00https://heartzone.it/la-terapia-farmacologica-dellobesita/2025-10-23T09:38:29+02:00https://heartzone.it/ruolo-del-laboratorio-e-profilassi-del-tev/2025-10-23T09:36:25+02:00https://heartzone.it/gian-mario-boffano/2025-10-22T23:46:27+02:00https://heartzone.it/luca-donofrio/2025-10-22T23:45:19+02:00https://heartzone.it/polmonite-profilassi-tev-come-e-per-quanto/2025-10-17T11:04:46+02:00https://heartzone.it/serve-o-no-spingere-per-la-vaccinazione-antiinfluenzale-lo-studio-kp-vaccinate/2025-10-17T09:13:05+02:00https://heartzone.it/definizione-e-criteri-diagnostici-dellobesita-clinica-ep-5/2025-10-17T09:14:00+02:00https://heartzone.it/definizione-e-criteri-diagnostici-dellobesita-clinica-ep-4/2025-10-17T09:13:53+02:00https://heartzone.it/glp-1-ra-orale-nuovi-sviluppi-i-risultati-dello-studio-attain-1-dal-congresso-easd-2025/2025-10-17T09:07:44+02:00https://heartzone.it/definizione-e-criteri-diagnostici-dellobesita-clinica-ep-3/2025-10-09T15:59:32+02:00https://heartzone.it/definizione-e-criteri-diagnostici-dellobesita-clinica-ep-2/2025-10-09T15:58:52+02:00https://heartzone.it/definizione-e-criteri-diagnostici-dellobesita-clinica-ep-1/2025-10-09T15:57:45+02:00https://heartzone.it/maria-barbaro/2025-10-09T15:53:48+02:00https://heartzone.it/paolo-marzullo/2025-10-09T15:53:18+02:00https://heartzone.it/fad-gratuita-2026/2026-03-03T16:29:57+01:00https://heartzone.it/quale-profilassi-nel-paziente-allettato-cronico/2025-10-02T19:26:28+02:00https://heartzone.it/lupdate-2025-delle-lineeguida-esc-sulla-dislipidemia-cosa-cambia-videointervista-con-il-cardiologo-interventista/2025-10-02T19:03:32+02:00https://heartzone.it/i-meccanismi-neuronali-sottesi-alla-regolazione-dellintroito-alimentare/2025-10-02T19:05:08+02:00https://heartzone.it/il-ruolo-centrale-della-funzione-adipocitaria/2025-10-02T18:59:20+02:00https://heartzone.it/i-messaggeri-dellinformazione-intestinale/2025-10-02T18:58:04+02:00https://heartzone.it/riduzione-intensa-di-ldl-c-e-placca-carotidea-evolocumab-nello-studio-caruso/2025-10-02T18:48:00+02:00https://heartzone.it/lo-stretto-rapporto-tra-il-tratto-gastrointestinale/2025-09-25T16:18:17+02:00https://heartzone.it/lo-stretto-rapporto-tra-dieta-microbiota-e-metabolismo/2025-09-25T16:17:00+02:00https://heartzone.it/marco-mazzella/2025-10-02T17:10:10+02:00https://heartzone.it/anna-luisa-leo/2025-10-02T17:10:12+02:00https://heartzone.it/giulia-bocedi/2025-10-02T17:10:14+02:00https://heartzone.it/federica-coccia/2025-10-02T17:11:44+02:00https://heartzone.it/clemente-giglio/2025-10-02T17:10:20+02:00https://heartzone.it/salvatore-rizzello/2025-10-02T17:10:18+02:00https://heartzone.it/salvatore-mandica/2025-10-02T17:10:20+02:00https://heartzone.it/alessandro-saibene/2025-10-02T17:10:22+02:00https://heartzone.it/chirurgia-ortopedica-minore-caviglia-e-piede/2025-09-26T18:10:34+02:00https://heartzone.it/serve-aumentare-il-potassio-nei-pazienti-ad-alto-rischio-di-aritmia-i-risultati-dello-studio-potcast/2025-09-25T16:25:36+02:00https://heartzone.it/massimiliano-caprio/2025-09-25T15:44:33+02:00https://heartzone.it/claudia-brufani/2025-09-25T15:44:25+02:00https://heartzone.it/laura-molteni/2025-09-25T15:44:15+02:00https://heartzone.it/giuseppe-pasimeni/2025-09-25T15:44:05+02:00https://heartzone.it/federica-barbagallo/2025-09-25T15:43:42+02:00https://heartzone.it/paolo-di-bartolo/2025-09-25T15:43:31+02:00https://heartzone.it/leonardo-russo/2025-09-25T15:43:16+02:00https://heartzone.it/sindrome-coronarica-acuta-e-resistenza-ad-asa-cosa-fare-delle-dosi-i-risultati-dello-studio-andaman/2025-09-22T10:29:14+02:00https://heartzone.it/asa-con-anticoagulante-nella-coronaropatia-cronica-meglio-di-no-i-risultati-dello-studio-acquatic/2025-09-22T10:28:13+02:00https://heartzone.it/si-puo-sospendere-lanticoagulante-dopo-ablazione-della-fa-i-risultati-dello-studio-alone-af/2025-09-22T10:27:04+02:00https://heartzone.it/terapia-antiaggregante-su-misura-per-la-pci-complessa-i-risultati-dello-studio-tailored-chip/2025-09-17T11:40:16+02:00https://heartzone.it/si-puo-fare-a-meno-di-asa-per-lima-a-basso-rischio-trattato-con-rivascolarizzazione-completa/2025-09-17T11:39:03+02:00https://heartzone.it/se-si-toglie-asa-subito-dopo-pci-per-sca/2025-09-17T11:37:55+02:00https://heartzone.it/profilassi-del-tev-aspetti-medico-legali/2025-09-17T11:35:15+02:00https://heartzone.it/asa-o-clopidogrel-quale-monoterapia-per-i-pazienti-con-coronaropatia-stabile-che-abbiano-o-meno-praticato-uno-dapt/2025-09-27T11:18:51+02:00https://heartzone.it/una-bassa-dose-di-apixaban-per-la-profilassi-prolungata-del-tev-provocato-qualche-distinguo/2025-09-11T14:58:22+02:00https://heartzone.it/e-davvero-una-victoria-i-risultati-dello-studio-victor-dal-congresso-esc-2025/2025-09-11T14:57:00+02:00https://heartzone.it/obesita-e-profilassi-la-prevenzione-in-chirurgia-bariatrica/2025-09-11T15:01:51+02:00https://heartzone.it/novita-importanti-per-la-terapia-antiaggregante-dopo-bypass-aortocoronarico/2025-09-27T11:18:57+02:00https://heartzone.it/ancora-dati-sui-betabloccanti-nel-post-infarto-proviamo-a-fare-il-punto/2025-09-09T12:10:24+02:00https://heartzone.it/the-sooner-the-better-i-risultati-dello-studio-dapa-act-hf-timi68-dal-congresso-esc-2025/2025-09-09T12:08:56+02:00https://heartzone.it/meno-emorragie-se-si-cerca-lhelicobacter-pylori-in-tutti-i-pazienti-con-ima/2025-09-27T11:18:59+02:00https://heartzone.it/obesita-e-profilassi-del-tev-quali-le-dosi/2025-09-04T16:18:35+02:00https://heartzone.it/donna-e-niente-fattori-di-rischio-controlla-linfiammazione/2025-09-04T16:14:50+02:00https://heartzone.it/hfref-il-quinto-pilastro-i-risultati-dello-studio-digit-hf/2025-09-04T16:13:29+02:00https://heartzone.it/ematopoiesi-clonale-rischio-cardiovascolare-e-colchicina-il-nuovo-che-avanza/2025-09-04T16:11:55+02:00https://heartzone.it/pipeline-lorizzonte-e-riabilitativo-per-gli-anziani-dopo-ima/2025-09-27T11:19:07+02:00https://heartzone.it/lo-studio-amalfi-quando-la-diagnosi-di-fa-si-fa-per-posta/2025-09-27T11:19:12+02:00https://heartzone.it/chirurgia-ortopedica-minore-spalla/2025-08-14T23:38:16+02:00https://heartzone.it/template-podcast/2025-09-27T11:19:17+02:00https://heartzone.it/sacubitril-valsartan-e-livelli-di-nt-probnp/2025-09-27T11:19:23+02:00https://heartzone.it/ma-un-bicchiere-di-vino-al-giorno-fa-bene-o-male-al-cuore/2025-01-16T16:21:29+01:00https://heartzone.it/il-caffe-e-la-salute-del-cuore-conta-quando-e-non-solo-quanto/2025-01-16T16:19:31+01:00https://heartzone.it/dopo-un-infarto-stop-al-fumo-o-sigaretta-elettronica/2025-07-10T16:52:16+02:00https://heartzone.it/nuovi-farmaci-per-lobesita-il-futuro-e-oltre-maritide-una-volta-al-mese-contro-lobesita/2025-10-01T16:15:05+02:00https://heartzone.it/infarto-con-o-senza-smurf-di-cosa-stiamo-parlando/2025-07-17T16:44:42+02:00https://heartzone.it/a-volte-ritornano-un-nuovo-studio-della-digitale-nello-scompenso-il-digit-hf/2025-09-27T11:19:29+02:00https://heartzone.it/ma-cose-tutta-questa-confidenza-finerenone-ed-empaglifozina-la-confidenza-dello-studio-confidence/2025-07-10T16:53:10+02:00https://heartzone.it/la-combinazione-di-dapagliflozin-e-spironolattone-nei-pazienti-con-hfpef-lo-studio-sogaldi-pef/2025-09-27T11:19:35+02:00https://heartzone.it/insufficienza-renale-e-profilassi-le-dosi/2025-07-10T16:52:04+02:00https://heartzone.it/dalla-coronaro-tc-un-aiuto-per-guidare-la-terapia-del-paziente-cad/2025-07-04T08:56:55+02:00https://heartzone.it/nuovi-farmaci-per-per-il-diabete-e-lobesita-sulla-soglia-di-una-rivoluzione/2025-07-04T08:58:02+02:00https://heartzone.it/profilassi-tev-nella-chirurgia-protesica-danca/2025-07-04T08:54:13+02:00https://heartzone.it/terapia-invasiva-o-conservativa-nello-nstemi-dopo-gli-80-conviene-sapere-anche-questo/2025-09-27T11:19:37+02:00https://heartzone.it/profilassi-tev-nella-chirurgia-protesica-del-ginocchio/2025-06-26T17:50:48+02:00https://heartzone.it/come-gestire-al-meglio-il-rischio-ldl-c-nei-pazienti-sca-5-domande-per-capire-meglio/2025-06-26T17:50:10+02:00https://heartzone.it/e-sempre-asa-la-monoterapia-antiaggregante-dopo-la-pci-la-risposta-da-una-metanalisi/2025-06-26T17:50:04+02:00https://heartzone.it/la-profilassi-nel-paziente-traumatologico-chirurgico-e-non/2025-06-12T19:24:37+02:00https://heartzone.it/fibrillazione-atriale-e-scompenso-a-frazione-di-eiezione-preservata-attenti-a-quei-due/2025-06-12T19:21:53+02:00https://heartzone.it/spironolattone-o-finerenone-nello-scompenso-cardiaco-a-frazione-di-eiezione-preservata-5-domande-per-capire-meglio/2025-06-12T20:24:57+02:00https://heartzone.it/profilassi-meccanica-del-tev-pro-e-contro/2025-06-05T15:25:11+02:00https://heartzone.it/stop-ai-betabloccanti-nel-post-infarto-ancora-dubbi/2025-06-05T15:22:51+02:00https://heartzone.it/fegato-grasso-farmaco-snello-i-risultati-dello-studio-essence/2025-06-05T15:22:32+02:00https://heartzone.it/il-rischio-di-stroke-nei-pazienti-fibrillanti-anticoagulati-le-sorprese-arrivano-dal-mondo-reale/2025-06-05T15:22:21+02:00https://heartzone.it/successo-per-obicetrapib-ma-sui-cetp-inibitori-non-avevamo-messo-una-pietra/2025-05-29T11:57:43+02:00https://heartzone.it/lpa-capiamone-di-piu/2025-05-29T11:56:27+02:00https://heartzone.it/ebpm-biosimilare-la-certezza-di-una-scelta/2025-05-29T11:54:31+02:00https://heartzone.it/la-profilassi-prolungata-nel-paziente-non-chirurgico/2025-05-22T17:13:57+02:00https://heartzone.it/statina-ezetimibe-qualche-conferma-e-qualche-sorpresa/2025-05-22T17:12:40+02:00https://heartzone.it/toracentesi-nello-scompenso-cardiaco-urgenza-terapeutica-o-mito-da-sfatare/2025-05-22T17:12:25+02:00https://heartzone.it/timing-di-inizio-della-profilassi-del-tev-nel-paziente-ospedalizzato/2025-05-09T08:53:58+02:00https://heartzone.it/restrizione-idrica-nello-scompenso-cardiaco-dogma-o-mito-da-sfatare/2025-05-09T00:04:19+02:00https://heartzone.it/il-rischio-dopo-pci-pesa-piu-il-colesterolo-o-linfiammazione/2025-05-08T23:59:36+02:00https://heartzone.it/il-rischio-residuo-oltre-i-livelli-di-ldl-c-una-lezione-dello-studio-reduce-it/2025-09-27T11:19:41+02:00https://heartzone.it/cannabis-e-salute-del-cuore/2025-04-30T17:59:32+02:00https://heartzone.it/parliamo-di-trombosi-del-ventricolo-sinistro-ci-sono-novita/2025-04-30T17:59:20+02:00https://heartzone.it/criticita-nelluso-di-asa-per-la-profilassi-del-tev/2025-04-30T17:58:57+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-17/2025-04-23T21:49:37+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-16/2025-04-23T21:49:01+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-15/2025-04-23T21:48:18+02:00https://heartzone.it/clopidogrel-o-asa-per-la-cad-cronica-i-risultati-dello-studio-smart-choice-3/2025-04-15T20:14:26+02:00https://heartzone.it/un-farmaco-buono-per-tutte-le-occasioni-semaglutide-nelarteriopatia-periferica-sintomatica-i-risultati-dello-studio-stride/2025-04-15T20:13:11+02:00https://heartzone.it/la-durata-ottimale-della-profilassi-del-tev-in-chirurgia-oncologica/2025-04-15T20:11:09+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-14/2025-04-23T21:47:38+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-13/2025-04-23T21:47:30+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-12/2025-04-23T21:47:20+02:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-9/2025-04-23T19:49:31+02:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-8/2025-04-23T19:49:25+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-11/2025-04-15T20:06:54+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-10/2025-04-15T20:06:35+02:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-9/2025-04-15T20:06:34+02:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-7/2025-04-15T20:05:48+02:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-6/2025-04-15T20:05:17+02:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-5/2025-04-15T20:04:50+02:00https://heartzone.it/colchicina-mentre-si-discute-arrivano-nuovi-dati-i-risultati-dello-studio-ekstrom/2025-04-10T11:59:57+02:00https://heartzone.it/questo-studio-po-esse-fero-po-esse-piuma-ferro-carbossimaltosio-nello-scompenso-cardiaco-i-risultati-dello-studio-fair-hf2/2025-04-10T11:58:19+02:00https://heartzone.it/anche-per-bocca-guai-a-chi-li-tocca-semaglutide-orale-e-outcome-cardiovascolare-i-risultati-dello-studio-soul/2025-04-10T11:57:44+02:00https://heartzone.it/rischio-di-tev-nella-chirurgia-oncologica-addominale/2025-04-10T11:54:35+02:00https://heartzone.it/dapagliflozin-protegge-anche-in-caso-di-tavi-lo-studio-dapatavi/2025-04-03T15:33:49+02:00https://heartzone.it/la-dose-ridotta-di-apixaban-e-ok-nel-trattamento-protratto-del-tev-in-oncologia/2025-04-03T15:32:23+02:00https://heartzone.it/sanguinamento-da-doac-fai-attenzione-a-questo/2025-03-27T12:20:23+01:00https://heartzone.it/scompenso-cardiaco-a-frazione-deiezione-preservata-call-to-action-qui-e-ora/2025-03-27T12:18:45+01:00https://heartzone.it/la-profilassi-del-tev-in-tempi-di-fast-track-surgery/2025-03-27T12:17:11+01:00https://heartzone.it/ancora-sui-doac-la-dose-ridotta-nel-tev-e-il-trattamento-dopo-emorragia-cerebrale-i-risultati-degli-studi-renove-e-prestige-af/2025-03-20T19:27:27+01:00https://heartzone.it/il-caprini-score-per-il-rischio-di-tev-il-piu-usato-eppure/2025-03-20T19:26:08+01:00https://heartzone.it/non-tutto-il-male-viene-per-nuocere-finerenone-e-declino-del-filtrato-renale-significato-e-prospettiva/2025-03-12T12:58:13+01:00https://heartzone.it/glp-1-ra-marcato-impatto-su-glicemia-e-molto-altro/2025-01-16T16:23:00+01:00https://heartzone.it/gli-effetti-dei-glp-1-ra-sullaterosclerosi/2025-01-16T16:22:44+01:00https://heartzone.it/il-diabetico-di-tipo2-un-paziente-cardiovascolare/2025-01-16T16:22:21+01:00https://heartzone.it/ma-con-un-doac-serve-sempre-un-ppi/2025-03-12T12:55:52+01:00https://heartzone.it/paga-ora-e-risparmia-poi-finerenone-e-la-funzione-renale-nel-paziente-con-hf-pef/2025-03-12T12:53:07+01:00https://heartzone.it/i-farmaci-per-la-profilassi-del-tev-leparina-una-scelta-ancora-azzeccata/2025-03-12T13:16:07+01:00https://heartzone.it/improve-bleeding-risk-score-per-il-rischio-emorragico/2025-03-06T17:30:54+01:00https://heartzone.it/interventi-e-procedure-nei-pazienti-in-doac-istruzioni-per-luso/2025-03-06T17:44:02+01:00https://heartzone.it/qualita-e-quantita-finerenone-e-qualita-della-vita-nello-studio-finearts-hf/2025-03-06T17:39:14+01:00https://heartzone.it/chi-prima-inizia-e-a-meta-dellopera-finerenone-ed-evento-indice-dentro-allo-studio-finearts-hf/2025-03-06T17:42:25+01:00https://heartzone.it/finearts-hf-uno-studio-di-un-certo-peso-finerenone-e-bmi-che-ci-azzecca/2025-03-06T17:41:02+01:00https://heartzone.it/il-punteggio-cha2ds2-vasc-nella-fa-va-in-pensione-come-cambiano-le-raccomandazioni-delle-llgg/2025-02-27T12:54:22+01:00https://heartzone.it/lamiloidosi-cardiaca-in-cinque-punti-seconda-parte/2025-02-27T12:54:03+01:00https://heartzone.it/il-padua-prediction-score-e-ancora-attuale/2025-02-27T12:53:48+01:00https://heartzone.it/la-profilassi-del-tev-si-sa-ma-non-si-fa/2025-02-27T12:53:26+01:00https://heartzone.it/i-nuovi-anticoagulanti-anti-fattore-xi-crederci-ancora-o-no/2025-02-03T17:05:30+01:00https://heartzone.it/lamiloidosi-cardiaca-in-cinque-punti-prima-parte/2025-02-03T16:34:53+01:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-4/2025-02-03T16:34:15+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-7/2025-02-06T17:41:45+01:00https://heartzone.it/specialisti-a-confronto-per-la-cura-dei-pazienti-fa/2025-01-23T11:21:05+01:00https://heartzone.it/fibrillazione-atriale-impatto-su-mortalita-e-morbidita-il-modello-danese/2025-01-23T11:20:50+01:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-3/2025-01-23T11:20:13+01:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-2/2025-01-23T11:19:55+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-8/2025-01-16T16:12:39+01:00https://heartzone.it/la-sindrome-post-embolia-polmonare-cosi-frequente/2025-01-07T13:45:14+01:00https://heartzone.it/infiammazione-e-rischio-cardiovascolare-qualcosa-ancora-non-torna/2025-01-07T13:52:27+01:00https://heartzone.it/linee-guida-esc-2024-fa-episodio-1/2025-01-07T13:45:57+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-7/2025-01-07T13:44:18+01:00https://heartzone.it/ridurre-tanto-la-lpa-si-puo-gli-studi-kraken-e-alpacar/2024-12-18T17:04:24+01:00https://heartzone.it/e-se-il-paziente-ha-una-valvola-biologica-e-magari-non-ha-fa-un-doac-da-subito-e-ok/2024-12-18T17:02:37+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-6/2024-12-18T16:56:06+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-6/2024-12-18T16:54:22+01:00https://heartzone.it/rivaroxaban-per-18-mesi-nei-pazienti-oncologici-con-embolia-polmonare-lo-studio-onco-pe/2024-12-09T12:45:48+01:00https://heartzone.it/proviamo-ad-arrestare-la-fa-i-dati-dello-studio-arrest-af-dal-recente-congresso-aha-2024/2024-12-04T19:27:27+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-5/2024-12-04T19:27:20+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-5/2024-12-04T19:26:16+01:00https://heartzone.it/laggiunta-di-un-fans-ai-doac-per-il-tev-quale-rischio-emorragico/2025-09-27T11:19:44+02:00https://heartzone.it/sulodexide-per-il-tev-parliamone/2024-12-04T19:29:10+01:00https://heartzone.it/fa-e-rischio-demenza-serve-un-doac-i-risultati-dello-studio-brain-af/2024-11-25T16:15:24+01:00https://heartzone.it/spironolattone-nella-cardiopatia-ischemica-fumo-o-arrosto/2024-11-25T16:22:45+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-4/2024-11-25T16:09:58+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-4/2024-11-25T16:09:14+01:00https://heartzone.it/luso-in-ospedale-di-sacubitril-valsartan-nello-scompenso-cardiaco-acuto-lo-studio-premier/2025-09-27T11:20:31+02:00https://heartzone.it/scompenso-cardiaco-a-frazione-deiezione-preservata-riduciamo-il-girovita/2024-11-20T10:09:02+01:00https://heartzone.it/prima-lablazione-e-poi-la-chiusura-dellauricola-e-niente-anticoagulante-per-la-fa-i-risultati-dello-studio-option/2024-11-20T10:05:43+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-3/2024-11-20T10:05:36+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-3/2024-11-20T10:05:29+01:00https://heartzone.it/il-nuovo-che-avanza-nuove-prospettive-nella-terapia-dello-scompenso-cardiaco-a-frazione-deiezione-preservata-hfpef/2024-11-20T10:05:21+01:00https://heartzone.it/leredita-di-empagliflozin-nella-nefroprotezione-il-follow-up-a-lungo-termine-dello-studio-empa-kidney/2025-09-27T11:20:39+02:00https://heartzone.it/i-risultati-che-non-ti-aspetti-colchicina-nellinfarto-miocardico-acuto-lo-studio-clear-synergy-oasis-9/2024-11-14T14:17:55+01:00https://heartzone.it/fa-sintomatica-o-asintomatica-quali-conseguenze/2024-11-14T14:17:44+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-2/2024-11-14T14:13:19+01:00https://heartzone.it/linee-guida-esc-2024-paad-episodio-1/2024-11-14T14:11:24+01:00https://heartzone.it/quando-i-guai-non-vengono-da-soli-gli-eventi-arteriosi-dopo-un-tev-e-viceversa/2024-11-07T15:41:50+01:00https://heartzone.it/scompenso-cardiaco-a-frazione-di-eiezione-ridotta-hfref-terapia-raccomandata-dalle-linee-guida-gdmt-e-outcome-una-relazione-pericolosa/2024-11-07T15:41:45+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-2/2024-11-07T15:41:40+01:00https://heartzone.it/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension-episodio-1/2024-11-07T15:41:37+01:00https://heartzone.it/qual-e-il-ruolo-dei-pcsk9i-nella-prevenzione-dello-stroke-facciamo-il-punto/2024-11-07T15:41:22+01:00https://heartzone.it/un-bolo-di-cortisone-nellima-puo-servire/2024-11-07T15:45:35+01:00https://heartzone.it/semaglutide-e-rene-nello-studio-select-oltre-al-rischio-cv-ce-di-piu/2024-11-07T15:45:26+01:00https://heartzone.it/il-timing-di-inizio-dei-doac-nellictus-capitolo-chiuso/2025-09-27T11:20:45+02:00https://heartzone.it/emoglobina-glicata-al-basale-e-rischio-cardiovascolare-una-sottoanalisi-dello-studio-select/2024-11-07T15:44:38+01:00https://heartzone.it/semaglutide-e-rischio-cardiovascolare-la-lezione-dello-studio-select/2024-10-24T15:53:47+02:00https://heartzone.it/nuova-arrivata-o-vecchia-conoscenza-entrambe-una-nuova-luce-sulla-sindrome-cardionefrometabolica/2024-11-07T15:44:28+01:00https://heartzone.it/luci-e-ombre-nella-profilassi-del-tev-per-il-paziente-medico/2024-10-24T15:53:26+02:00https://heartzone.it/chi-prima-comincia-e-a-meta-dellopera-i-dati-di-dapaglifozina-in-rapporto-al-timing-di-inizio-dallospedalizzazione-per-scompenso-cardiaco/2024-11-07T15:44:17+01:00https://heartzone.it/avanti-a-piccoli-passi-verso-levidenza-la-chiusura-dellauricola-nella-fa/2024-11-07T15:43:49+01:00https://heartzone.it/lunione-fa-la-forza-antagonisti-recettoriali-dei-mineralcorticoidi-e-sglt2i-nello-scompenso-cardiaco-a-frazione-deiezione-preservata-o-lievemente-ridotta/2024-11-07T15:43:42+01:00https://heartzone.it/cuore-ingolfato-diamo-una-sistemata-alle-alle-valvole/2024-11-07T15:43:59+01:00https://heartzone.it/beneficio-a-lungo-termine-di-finerenone-nei-pazienti-con-scompenso-cardiaco/2025-09-27T11:20:51+02:00https://heartzone.it/quando-due-non-e-meglio-che-uno-monoterapia-anticoagulante-o-anticoagulante-piu-antiaggregante-nel-paziente-con-fa-e-cad-stabile/2024-11-07T15:43:21+01:00https://heartzone.it/si-puo-evitare-il-ricovero-con-la-furosemide-sottocute-nei-pazienti-scompensati/2025-09-27T11:20:58+02:00https://heartzone.it/and-the-oscar-goes-to-mra/2024-10-01T16:28:32+02:00https://heartzone.it/la-profilassi-primaria-nei-pazienti-a-rischio-molto-elevato-il-caso-della-stenosi-carotidea-e-lefficacia-di-evolocumab-nello-studio-slice-cea/2024-09-26T08:36:12+02:00https://heartzone.it/cambiare-anticoagulante-fa-male-il-caso-degli-anticoagulanti-per-la-fibrillazione-atriale/2024-09-25T14:34:09+02:00https://heartzone.it/invasiva-o-no-negli-anziani-fragili-con-nstemi-lo-studio-senior-rita-fa-discutere/2024-09-18T18:30:41+02:00https://heartzone.it/la-terapia-ipocolesterolemizzante-per-la-prevenzione-secondaria-nella-cardiologia-italiana-lo-studio-bring-up-prevenzione/2024-09-18T18:30:25+02:00https://heartzone.it/colchicina-nello-scompenso-cardiaco-qualche-considerazione-dopo-lo-studio-colica/2024-09-09T12:15:32+02:00https://heartzone.it/la-prima-volta-non-si-scorda-mai-mra-e-hfpef-le-novita-dello-studio-finearts-hf/2024-09-09T17:59:13+02:00https://heartzone.it/betabloccanti-nel-post-infarto-miocardico-pronti-per-la-pensione-la-lezione-dello-studio-abyss/2024-09-04T11:11:35+02:00https://heartzone.it/effetti-della-riduzione-intensiva-precoce-e-protratta-del-colesterolo-non-hdl-dopo-infarto-miocardico-i-dati-del-registro-swedeheart/2024-09-04T11:11:28+02:00https://heartzone.it/lpa-elevata-qualcuno-dice-asa/2024-08-02T18:32:50+02:00https://heartzone.it/la-terapia-anticoagulante-nel-paziente-epatopatico-con-fa-una-scelta-tra-due-fuochi/2024-09-25T14:36:39+02:00https://heartzone.it/vericiguat-e-scompenso-ce-trippa-per-gatti/2024-09-25T14:36:29+02:00https://heartzone.it/lo-studio-hf-opt-e-lottimizzazione-della-terapia-raccomandata-per-lo-scompenso-questione-di-tempo/2024-09-25T14:36:15+02:00https://heartzone.it/il-colesterolo-ldl-nelle-sca-ridurlo-tanto-e-da-subito-siamo-daccordo-e-poi/2024-09-25T14:36:21+02:00https://heartzone.it/lo-studio-step-hf-pef-e-la-sottoanalisi-in-rapporto-alle-diverse-frazioni-di-eiezione/2025-09-27T11:21:04+02:00https://heartzone.it/alcune-forti-evidenze-di-grandi-studi-clinici-del-passato-possono-invecchiare/2024-09-25T14:35:58+02:00https://heartzone.it/i-glp-1ra-nello-scompenso-utili-o-inutili/2024-09-25T14:35:46+02:00https://heartzone.it/ma-non-dovevamo-vederci-piu-asa-in-prevenzione-primaria/2024-09-11T16:09:38+02:00https://heartzone.it/la-metanalisi-degli-studi-step-hf-con-semaglutide/2025-09-27T11:21:10+02:00https://heartzone.it/gliflozine-nello-scompenso-come-funzionano/2024-09-11T16:09:05+02:00https://heartzone.it/trombectomia-percutanea-con-catetere-ci-sono-novita/2024-09-11T16:08:56+02:00https://heartzone.it/stiamo-davvero-imparando-a-ridurre-il-colesterolo-ldl/2024-09-11T16:08:44+02:00https://heartzone.it/ipocolesterolemizzanti-e-rischio-di-tev-a-volte-ritornano/2024-09-11T16:08:36+02:00https://heartzone.it/ferro-e-scompenso-cardiaco-rivediamo-insieme-le-evidenze-scientifiche/2024-09-11T16:08:29+02:00https://heartzone.it/tempo-di-pert-anche-in-italia/2024-09-11T16:08:18+02:00https://heartzone.it/embolia-polmonare-a-rischio-intermedio-ne-sappiamo-di-piu/2024-09-11T16:08:12+02:00https://heartzone.it/infiammazione-coronarica-linizio-di-una-nuova-strada/2024-07-27T10:26:58+02:00https://heartzone.it/fa-e-cancro/2024-07-27T10:26:44+02:00https://heartzone.it/non-ho-piu-eta-cambia-qualcosa-per-le-statine-negli-anziani/2024-07-27T10:26:28+02:00https://heartzone.it/la-profilassi-secondaria-dopo-stroke-ischemico-lo-studio-non-e-positivo-ma-convince/2025-09-27T11:21:19+02:00https://heartzone.it/semaglutide-e-nefroprotezione/2025-09-27T11:21:25+02:00https://heartzone.it/lo-scompenso-che-non-si-ricompensa-con-furosemide-come-forzare-la-mano/2024-07-04T12:46:26+02:00https://heartzone.it/la-lipoproteina-a-nella-gestione-del-rischio-cardiovascolare/2024-06-27T12:56:39+02:00https://heartzone.it/gli-effetti-pleiotropici-dei-pcsk9i-fatti-o-fantasie/2025-09-27T11:21:31+02:00https://heartzone.it/andexanet-alfa-nellemorragia-cerebrale-da-doac-anti-fxa/2024-06-17T16:45:28+02:00https://heartzone.it/lo-studio-effort-e-le-novita-nel-trattamento-dellinsufficienza-mitralica-secondaria/2025-09-27T11:21:39+02:00https://heartzone.it/i-dubbi-sul-vecchio-amico-i-beta-bloccanti-nello-scompenso-a-frazione-di-eiezione-preservata/2024-06-27T12:56:23+02:00https://heartzone.it/artrite-reumatoide-e-tev-attenti-a-quei-due/2024-06-04T12:52:44+02:00https://heartzone.it/colchicina-nei-pazienti-diabetici-con-infarto-miocardico-recente/2025-09-27T11:21:43+02:00https://heartzone.it/cala-il-sipario-sulle-hdl/2024-09-04T12:42:56+02:00https://heartzone.it/hai-bisogno-di-una-statina-te-lo-dice-lapp/2024-09-04T12:43:05+02:00https://heartzone.it/le-lezioni-dello-studio-prevent/2024-09-04T12:43:11+02:00https://heartzone.it/se-parliamo-di-rischio-residuo-parliamo-di-icosapent/2024-06-04T12:52:00+02:00https://heartzone.it/a-goal-o-non-a-goal-di-ldl-c-si-decide-alla-dimissione/2024-06-04T12:51:54+02:00https://heartzone.it/siamo-pronti-per-colchicina-nel-cardiovascolare/2024-06-04T12:51:39+02:00https://heartzone.it/asa-una-sola-taglia-dose-per-tutti-i-pazienti/2024-05-15T14:56:19+02:00